First look: testing a pill version of an ALS drug
NCT ID NCT04176224
Summary
This small, early-stage study tested how the body absorbs and processes an oral liquid form of edaravone, a drug used for ALS. It involved 9 Japanese patients with ALS to measure drug levels in the blood and check for safety. The goal was to understand how the drug behaves in the body when taken by mouth, which could be more convenient than the current intravenous (IV) infusion.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for JAPANESE PATIENTS WITH ALS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigational site
Tokyo, Japan
Conditions
Explore the condition pages connected to this study.